Home・Список акций・GE HealthCare Technologies

GE HealthCare Technologies

Открыт

СекторЗдравоохранение

72.2 -0.69

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

70.68

Макс.

72.98

Ключевые показатели
By Trading Economics
Доход	163M 574M
Продажи	164M 5.3B
P/E Средняя по отрасли	16.54 57.002
Прибыль на акцию	1.13
Дивидендная доходность	0.2
Рентабельность продаж	10.84
Сотрудники	54,000
EBITDA	52M 807M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+8.69% upside

Дивиденды
By Acuity
Дивидендная доходность Средняя по отрасли	0.20% 2.22%
Следующий отчет о доходах	28 окт. 2026 г.
Дата следующей выплаты дивидендов	14 авг. 2026 г.
Следующая эксдивидендная дата	23 окт. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	5.1B 33B
Предыдущая цена открытия	72.89
Предыдущая цена закрытия	72.2

Новостные настроения

By Acuity

16%

84%

23 / 340 Рейтинг в Healthcare

GE HealthCare Technologies График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 авг. 2026 г., 20:06 UTC

GE Healthcare Technologies shares are lower today amid broader market declines. The stock remains above its 20-day moving average despite earlier gains.

10 авг. 2026 г., 19:16 UTC

GE Healthcare Technologies shares are higher today, reflecting gains since Friday's close. No specific news was identified to explain the price movement.

7 авг. 2026 г., 23:36 UTC

No specific news for GE Healthcare Technologies. The stock traded roughly flat after-market, remaining near the upper end of its one-month range.

6 авг. 2026 г., 19:46 UTC

GE Healthcare Technologies remains roughly flat as price fluctuations continue. The stock trades near the upper end of its one-month range and above its moving average.

5 авг. 2026 г., 19:56 UTC

News

GE Healthcare reported strong Q2 results with $5.30 billion in revenue and adjusted EPS of $1.13, but shares are trading lower since Tuesday's close.

4 авг. 2026 г., 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

3 авг. 2026 г., 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

31 июл. 2026 г., 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

30 июл. 2026 г., 22:31 UTC

News

GE Healthcare Technologies reported Q2 revenue of $5.30 billion, but shares are trading lower after highlighting challenges in the Patient Care Solutions segment.

29 июл. 2026 г., 23:21 UTC

GE Healthcare shares are lower in after-market hours, reflecting a decline after briefly recovering earlier in the session. No specific news was identified.

28 июл. 2026 г., 23:41 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, showing volatility with no specific news identified to explain the movement.

27 июл. 2026 г., 23:16 UTC

GE Healthcare shares are trading higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

24 июл. 2026 г., 20:03 UTC

Event

News

GE Healthcare shares decline as CFO Jay Saccaro steps down amid preliminary Q2 results showing revenue growth to $5.295 billion.

23 июл. 2026 г., 23:41 UTC

Event

News

GE Healthcare appointed George Newcomb as interim CFO and reported $5.30 billion in second-quarter revenue, with shares higher in after-market trading.

22 июл. 2026 г., 23:31 UTC

GE Healthcare Technologies shares moved higher in after-market trading, despite earlier fluctuations. Broader market dynamics include rising crude oil prices amid U.S.-Iran tensions.

21 июл. 2026 г., 23:46 UTC

GE Healthcare shares are higher in after-market hours amid positive market sentiment from recent earnings reports, though they remain below the 20-day moving average.

20 июл. 2026 г., 16:31 UTC

News

GE Healthcare Technologies has launched MIM Anyware, enhancing remote access to its software portfolio. Shares are trading higher, breaking from a recent upward trend.

Сравнение c конкурентами

Изменение цены

GE HealthCare Technologies Прогноз

Целевая цена

By TipRanks

8.69% рост

Прогноз на 12 месяцев

Средняя 79.07 USD 8.69%

Максимум 92 USD

Минимум 70 USD

Основано на мнении 14 аналитиков Wall Street, спрогнозировавших целевые цены для GE HealthCare Technologies на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

14 ratings

Покупка

Удержание

Продажа

Основано на мнении 14 аналитиков, присваивавших рейтинги акциям GE HealthCare Technologies – Данные за последние 3 месяца.

Настроения

By Acuity

23 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.